October 24, 2017Comments Off on Americans overspend $73bn on branded drugs Posted in: Insights
File this under ‘unintended consequences.’ A number of health care organizations are complaining that a final guideline the US Food and Drug Administration recently released for naming both biologic medicines…
The post Americans overspend $73bn on branded drugs appeared first on DrugPatentWatch - Make Better Decisions.
Comments are closed.
Get email updates
Get new actionable insights and updates from BiotechBlog